Neomycin and polymyxin B sulfate is a topical antibiotic combination used to treat or prevent bacterial infections in the eye and ear. It works by disrupting bacterial cell walls and protein synthesis, targeting many gram-positive and gram-negative bacteria.
This medication is not systemic-it acts locally at the site of application. It is available in ophthalmic (eye drop) and otic (ear drop) formulations, often combined with corticosteroids in certain cases. The two antibiotics work synergistically: neomycin targets ribosomes in bacterial cells, while polymyxin B disrupts membrane integrity.
According to the U.S. National Library of Medicine, neomycin and polymyxin B sulfate is approved for use in patients aged 1 month and older for ophthalmic applications and for those 12 years and older for otic use. It is not effective against viruses or fungi.
Neomycin is an aminoglycoside antibiotic derived from Streptomyces fradiae. It binds irreversibly to the 30S ribosomal subunit in bacteria, causing misreading of mRNA and premature termination of protein chains. This leads to the production of nonfunctional proteins and bacterial death.
Polymyxin B sulfate is a cyclic polypeptide antibiotic produced by Bacillus polymyxa. It inserts into the outer membrane of gram-negative bacteria, displacing divalent cations (like Mg²⁺) that stabilize the membrane. This causes membrane destabilization, leakage of cellular contents, and rapid cell lysis.
The combination is effective against common ocular and otic pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae. Clinical trials show it reduces infection rates by 68% in postoperative eye surgeries when used prophylactically.
Neomycin and polymyxin B sulfate is formulated in two primary delivery systems:
| Type | Active Ingredients | Common Use | Typical Concentration |
|---|---|---|---|
| Ophthalmic drops | Neomycin 3.5 mg/mL, Polymyxin B 10,000 units/mL | Conjunctivitis, corneal abrasions, post-op prophylaxis | 0.3% neomycin, 10,000 U/mL polymyxin B |
| Otic solution | Neomycin 3.5 mg/mL, Polymyxin B 10,000 units/mL | Otitis externa, infected ear wounds | Same as above |
For eye use, the standard regimen is one drop in the affected eye every 4 hours during waking hours for up to 7 days. For ear infections, 5 drops are instilled twice daily for 7 days. The solution must be sterile and stored at room temperature, away from light.
A 2021 study published in *Antimicrobial Agents and Chemotherapy* found that 87% of patients with mild to moderate bacterial conjunctivitis showed symptom resolution within 48 hours of starting treatment with this combination.
Many users assume this medication treats viral or fungal infections. It does not. Using it for conditions like herpes simplex keratitis or fungal otitis can delay proper care and worsen outcomes.
Another misconception is that it's safe for long-term use. Prolonged exposure increases the risk of ototoxicity and nephrotoxicity, especially in patients with renal impairment. The FDA warns against using it for more than 10 consecutive days without monitoring.
Neomycin is associated with rare but serious allergic reactions. A 2019 report in *JAMA Ophthalmology* documented five cases of severe ocular surface inflammation linked to neomycin-containing drops over a 12-month period. All required discontinuation and steroid therapy.
In 2022, a 45-year-old patient underwent cataract surgery. Postoperatively, they developed redness, discharge, and photophobia in the left eye. Cultures confirmed Pseudomonas aeruginosa. The surgeon prescribed neomycin and polymyxin B sulfate ophthalmic drops, one drop every 4 hours for 7 days.
By day 3, symptoms improved. By day 7, the eye was clear with no signs of infection. Visual acuity returned to 20/20. No adverse events were reported during follow-up.
This case illustrates the drug's effectiveness when used correctly and highlights the importance of accurate diagnosis before initiating treatment.
If irritation, swelling, or worsening pain occurs after use, discontinue and consult a provider. These may indicate hypersensitivity or secondary infection. Do not share eye or ear drops between individuals.
Patients with known allergies to aminoglycosides or polymyxins should avoid this medication. Those with kidney disease require dose adjustment or alternative therapy.
Neomycin and polymyxin B sulfate remains a widely used, effective tool in managing localized bacterial infections. Its success depends on correct diagnosis, adherence to dosing schedules, and awareness of contraindications.